---
document_datetime: 2024-10-17 09:43:23
document_pages: 7
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/cinacalcet-mylan-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
document_name: cinacalcet-mylan-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
version: success
processing_time: 10.974823
conversion_datetime: 2025-12-29 23:25:18.699881
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Cinacalcet Viatris

Procedural steps taken and scientificinformation after the authorisation

| Application number   | Scope                                                                                        | Opinion/ Notification 1 issued on   | Commission Decision Issued2 / amended on   | Product Information affected3   | Summary   |
|----------------------|----------------------------------------------------------------------------------------------|-------------------------------------|--------------------------------------------|---------------------------------|-----------|
| IG/1772              | A.2.a-Administrative change -Change in the (invented) name of the medicinal product for CAPs | 15/10/2024                          |                                            | SmPC, Labelling and PL          |           |
| N/0025               | Minorchange inlabellingorpackageleafletnot connected with theSPC(Art.61.3 Notification)      | 18/03/2024                          |                                            | PL                              |           |

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

| IB/0024   | C.I.11.z - Introduction of, or change(s) to, the obligations and conditions of a marketing authorisation,including the RMP-Othervariation                                                                                                                                                                                                                                    | 06/10/2023   | n/a   |    |                |
|-----------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|-------|----|----------------|
| I1/0023/G | Thiswasanapplicationfor agroupofvariations. PleaserefertotheRecommendationssection B.II.d.2.d-Change in testprocedure for the finished product - Other changes to a test procedure (including replacement or addition) B.I.a.1.b-Change in the manufacturer of ASorof a startingmaterial/reagent/intermediateforAS- Introductionofamanufacturer of theASsupported by an ASMF | 14/09/2023   | n/a   |    | Not applicable |
| N/0022    | Minor change in labelling or package leaflet not connected with the SPC(Art.61.3 Notification)                                                                                                                                                                                                                                                                               | 17/04/2023   |       | PL |                |
| N/0021    | Minorchangeinlabellingorpackageleafletnot connected with theSPC(Art.61.3 Notification)                                                                                                                                                                                                                                                                                       | 12/09/2022   |       | PL |                |
| 11/0016   | B.I.a.1.b-ChangeinthemanufacturerofASorof a startingmaterial/reagent/intermediateforAS- Introductionofamanufacturer of theASsupported by an ASMF                                                                                                                                                                                                                             | 22/04/2022   | n/a   |    |                |
| N/0020    | Minorchangeinlabellingorpackageleafletnot connected with theSPC(Art.61.3 Notification)                                                                                                                                                                                                                                                                                       | 06/04/2022   |       | PL |                |
| IB/0019   | B.II.e.1.b.1-Change in immediate packaging of the finished product - Change in type/addition of a new                                                                                                                                                                                                                                                                        | 17/12/2021   | n/a   |    |                |

<div style=\"page-break-after: always\"></div>

|           | container-Solid,semi-solid and non-sterileliquid pharmaceuticalforms                                                                                                                                                                          |            |            |                                  |                                                                                                                                                                                                                                      |
|-----------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| T/0017    | Transfer of MarketingAuthorisation                                                                                                                                                                                                            | 12/08/2021 | 29/09/2021 | SmPC, Labelling and PL           |                                                                                                                                                                                                                                      |
| IB/0015   | B.II.f.1.b.1-Stability of FP-Extension of the shelf lifeof thefinishedproduct-Aspackagedforsale (supported byreal time data)                                                                                                                  | 20/07/2021 | 29/09/2021 | SmPC                             |                                                                                                                                                                                                                                      |
| IB/0014   | C.I.2.a-Change in the SPC, Labelling orPL of a generic/hybrid/biosimilar products following assessmentofthesamechangeforthereference product - Implementation of change(s) for which NO new additional dataisrequired tobesubmittedby the MAH | 27/05/2021 | 17/06/2021 | SmPC and PL                      |                                                                                                                                                                                                                                      |
| IAIN/0013 | B.II.e.5.a.1 - Change in pack size of the finished product - Change in the number of units (e.g. tablets,ampoules,etc.)in a pack-Change within the range of the currently approved pack sizes                                                 | 17/11/2020 | 17/06/2021 | SmPC and Labelling               |                                                                                                                                                                                                                                      |
| R/0011    | Renewalof themarketing authorisation.                                                                                                                                                                                                         | 23/07/2020 | 24/09/2020 | SmPC, Annex II, Labelling and PL | Based on the review of data on quality, safety and efficacy, theCHMPconsidered thatthebenefit-riskbalanceof CinacalcetMylanintheapprovedindicationremains favourableandrecommendedanunlimitedvalidityforthe Marketing Authorisation. |
| 6000/II   | B.I.a.1.b-Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - Introductionofamanufacturerof theASsupported by an ASMF                                                                                    | 03/09/2020 | n/a        |                                  |                                                                                                                                                                                                                                      |

<div style=\"page-break-after: always\"></div>

| IB/0012   | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO newadditional dataisrequiredtobesubmittedby the MAH                                                                                                                                                                                                                                                                                                        | 30/04/2020   | 02/06/2020   | SmPC            |           |
|-----------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|--------------|-----------------|-----------|
| IA/0010   | A.7-Administrative change-Deletion of manufacturing sites                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    | 26/02/2020   | 02/06/2020   | Annex II and PL |           |
|           | B.II.b.2.c.1-Change to importer,batch release arrangements and quality control testing of the FP - Replacementoradditionofamanufacturer responsibleforimportation and/orbatchrelease- Not including batch control/testing                                                                                                                                                                                                                                                                                                                                    | 27/01/2020   | 02/06/2020   | Annex II and PL | IAIN/0008 |
| IB/0007/G | Thiswas an applicationfor a group of variations. B.I.a.1.a-Change in the manufacturer of AS or of a startingmaterial/reagent/intermediateforAS-The proposed manufacturer is part of the same pharmaceuticalgroupasthecurrentlyapproved manufacturer B.I.a.1.a-Change in the manufacturer of ASor of a starting material/reagent/intermediate for AS - The proposedmanufacturerispartofthesame pharmaceutical group as the currently approved manufacturer B.I.a.2.e-Changes in the manufacturingprocess of theAS-Minor change to therestrictedpartof an ASMF | 18/11/2019   | n/a          |                 |           |

<div style=\"page-break-after: always\"></div>

|           | B.I.b.1.c-Change in thespecificationparameters and/or limits of an AS, starting material/intermediate/reagent-Additionofanew specification parameter to the specification with its corresponding test method B.I.b.1.c - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent-Additionofanew specification parameter to the specification with its corresponding test method B.I.b.1.c - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent-Additionofanew specification parameter to the specification with its corresponding test method B.I.b.1.d - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent-Deletionof anon- significant specification parameter (e.g. deletion of anobsoleteparameter) B.I.d.1.a.4-Stability ofAS-Change in the re-test period/storageperiod-Extension orintroductionof a re-test period/storage period supported by real time   |            |            |                        |
|-----------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|
| IB/0006/G | Thiswas an applicationfor a groupofvariations. B.II.e.5.a.1-Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change within the range of the currently approved pack sizes B.II.e.5.a.1 - Change in pack size of the finished                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     | 29/10/2019 | 02/06/2020 | SmPC, Labelling and PL |

<div style=\"page-break-after: always\"></div>

|         | product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change within the range of the currently approved pack sizes B.II.e.5.a.2 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change outside the range of the currently approved pack sizes   |            |            |                        |           |
|---------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|-----------|
|         | C.I.11.z -Introduction of, or change(s) to, the obligations and conditions of a marketing authorisationï¼ŒincludingtheRMp-Othervariation                                                                                                                                                                                                                | 17/05/2019 | n/a        |                        | IB/0005   |
| N/0004  | Minor change in labelling or package leaflet not connected with theSPC(Art.61.3Notification)                                                                                                                                                                                                                                                          | 22/03/2019 | 23/08/2019 | PL                     |           |
| IB/0003 | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessmentofthesamechangeforthereference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH                                                                                                 | 07/09/2018 | 23/08/2019 | SmPC, Labelling and PL |           |
|         | Thiswas anapplicationfor agroupofvariations. B.I.a.3.a -Change inbatch size(including batch size ranges) of AS or intermediate - Up to 10-fold increase compared to the originally approved batch size B.II.b.4.b -Change in the batch size (including batch size ranges) of the finished product -Downscaling down to10-fold                         | 24/05/2017 | n/a        |                        | IA/0002/G |

<div style=\"page-break-after: always\"></div>

| IAIN/0001   | C.I.3.a - Change(s) in the SPC, Labelling or PL intended to implement the outcome of a procedure concermingPSURorPASSortheoutcomeof the assessment done under A 45/46- Implementation of wording agreed by the competent authority   | 11/01/2017   | 11/01/2018   | SmPC and PL   |
|-------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|--------------|---------------|